Advertisement
Screener

CAPRICOR THERAPEUTICS, INC. (CAPR) Adjustments to Additional Paid in Capital, Warrant Issued

2.0 / 5 stars · 33/81 Roast Me

CAPRICOR THERAPEUTICS, INC. Adjustments to Additional Paid in Capital, Warrant Issued

CAPRICOR THERAPEUTICS, INC. (CAPR) reported Adjustments to Additional Paid in Capital, Warrant Issued of -$611.90 thousand for the 12-month period ending 2012-12-31, per its 10-Q filed 2013-11-14.

Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital

us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2013-11-14

  • CAPRICOR THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2012-12-31 was $0.00.
  • CAPRICOR THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2012-09-30 was $0.00.
Period endAdjustments to Additional Paid in Capital, Warrant Issued 3 monthAdjustments to Additional Paid in Capital, Warrant Issued 6 monthAdjustments to Additional Paid in Capital, Warrant Issued 9 monthAdjustments to Additional Paid in Capital, Warrant Issued 12 month
2012-12-31$0.00
derived: 10-Q 12 month − 10-Q 9 month · filed 2013-11-14
$0.00
derived: sum of 2 quarters · filed 2013-11-14
-$611.90K
10-Q · filed 2013-11-14
2012-09-30$0.00
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-06-21
-$611.90K
10-Q · filed 2013-06-21
2012-06-30-$611.90K
10-Q/A · filed 2012-09-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
PUMA BIOTECHNOLOGY, INC. (PBYI)United States$0.507B15.53
ARVINAS, INC. (ARVN)United States$0.510B58.38
Ovid Therapeutics Inc. (OVID)United States$0.487B-14.41
ASSEMBLY BIOSCIENCES, INC. (ASMB)United States$0.481B-13,053.96
Evolus, Inc. (EOLS)United States$0.519B-13.32
CRESCENT BIOPHARMA, INC. (CBIO)United States$0.529B-5.20
Indaptus Therapeutics, Inc. (INDP)United States$0.537B
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63